STOLL ROGER G PHD 4

4 · DELCATH SYSTEMS, INC. · Filed May 28, 2024

Insider Transaction Report

Form 4

Period: 2024-05-23

DELCATH SYSTEMS, INC.DCTH

STOLL ROGER G PHD

Director

Transactions

Disposition to Issuer
Stock Option (Right to Buy)
2024-05-23−142→ 0 total
Exercise: $196.70Exp: 2029-02-01→ Common Stock (142 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2024-05-23−40,000→ 0 total
Exercise: $11.67Exp: 2030-10-01→ Common Stock (40,000 underlying)
Award
Stock Option (Right to Buy)
2024-05-23+9,000→ 9,000 total
Exercise: $10.16Exp: 2026-05-23→ Common Stock (9,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2024-05-23−9,000→ 0 total
Exercise: $10.16Exp: 2031-08-05→ Common Stock (9,000 underlying)
Award
Stock Option (Right to Buy)
2024-05-23+142→ 142 total
Exercise: $196.70Exp: 2026-05-23→ Common Stock (142 underlying)
Award
Stock Option (Right to Buy)
2024-05-23+40,000→ 40,000 total
Exercise: $11.67Exp: 2026-05-23→ Common Stock (40,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2024-05-23−19,682→ 0 total
Exercise: $7.25Exp: 2033-06-12→ Common Stock (19,682 underlying)
Award
Stock Option (Right to Buy)
2024-05-23+19,682→ 19,682 total
Exercise: $7.25Exp: 2026-05-23→ Common Stock (19,682 underlying)
Award
Stock Option (Right to Buy)
2024-05-23+9,000→ 9,000 total
Exercise: $6.24Exp: 2026-05-23→ Common Stock (9,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2024-05-23−9,000→ 0 total
Exercise: $6.24Exp: 2023-05-04→ Common Stock (9,000 underlying)

Footnotes (6)

[F1]This option was previously reported as covering 100,000 shares at an exercise price of $0.281 per share, but was adjusted to reflect the stock split that occurred on December 24, 2019.
[F2]The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on February 1, 2019 and is fully vested.
[F3]The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 23, 2020 and is fully vested.
[F4]The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on August 5, 2021 and is fully vested.
[F5]The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 4, 2022 and is fully vested.
[F6]The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 12, 2023 and is fully vested.

Documents

1 file

4
form4-05282024_080551.xmlPrimary